These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 11180092
1. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease. Mora J, Cheung NK, Chen L, Qin J, Gerald W. Cancer; 2001 Jan 15; 91(2):435-42. PubMed ID: 11180092 [Abstract] [Full Text] [Related]
2. Loss of heterozygosity for chromosome 14q in neuroblastoma. Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS. Med Pediatr Oncol; 2001 Jan 15; 36(1):28-31. PubMed ID: 11464899 [Abstract] [Full Text] [Related]
3. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM. Med Pediatr Oncol; 2001 Jan 15; 36(1):32-6. PubMed ID: 11464900 [Abstract] [Full Text] [Related]
5. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Martinsson T, Sjöberg RM, Hedborg F, Kogner P. Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654 [Abstract] [Full Text] [Related]
7. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T. Med Pediatr Oncol; 2001 Jan 01; 36(1):67-74. PubMed ID: 11464909 [Abstract] [Full Text] [Related]
10. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Gehring M, Berthold F, Edler L, Schwab M, Amler LC. Cancer Res; 1995 Nov 15; 55(22):5366-9. PubMed ID: 7585602 [Abstract] [Full Text] [Related]
12. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Ohtsu K, Hiyama E, Ichikawa T, Matsuura Y, Yokoyama T. Clin Cancer Res; 1997 Jul 15; 3(7):1221-8. PubMed ID: 9815803 [Abstract] [Full Text] [Related]
13. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R. N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999 [Abstract] [Full Text] [Related]
14. Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Mora J, Cheung NK, Chen L, Qin J, Gerald W. Clin Cancer Res; 2001 May 25; 7(5):1358-61. PubMed ID: 11350906 [Abstract] [Full Text] [Related]
17. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT. J Clin Oncol; 2005 Sep 20; 23(27):6466-73. PubMed ID: 16116152 [Abstract] [Full Text] [Related]